05, Sep 2023

The Crucial Role of CDMOs in South America

Democratizing Access to Science: The Crucial Role of Contract Development and Manufacturing Organizations (CDMOs) in South America

In the pursuit of global progress, the democratization of access to science stands as a pivotal objective. Contract Development and Manufacturing Organizations (CDMOs) have emerged as potent facilitators in this endeavor, playing a vital role in advancing scientific research and innovation. The strategic presence of CDMOs in South America offers a transformative pathway to ensure equitable access to scientific advancements, fostering collaboration, and nurturing scientific growth. This essay delves into the key reasons why CDMOs in South America are instrumental in democratizing access to science.


  • Unlocking Scientific Potential: South America is a reservoir of diverse ecosystems, harboring an immense variety of flora and fauna. This biological richness presents an unparalleled opportunity for scientific exploration and discovery. CDMOs established in the region can harness this biodiversity to develop novel pharmaceuticals, biotechnological products, and scientific solutions that address global challenges. By tapping into the region's unique genetic resources, CDMOs can contribute to a wider array of scientific breakthroughs, ensuring that the benefits of scientific progress are distributed more equitably.
  • Collaborative Knowledge Exchange: The establishment of CDMOs in South America fosters an ecosystem of collaborative knowledge exchange. It brings together scientists, researchers, and experts from diverse backgrounds to work collectively on cutting-edge projects. This collaborative spirit nurtures innovation and promotes the sharing of insights, technologies, and methodologies, ultimately accelerating scientific progress. CDMOs become hubs of learning and collaboration, democratizing access to the collective wisdom of the global scientific community.
  • Capacity Building and Skill Enhancement: CDMOs in South America serve as catalysts for capacity building and skill enhancement. By providing training and exposure to advanced research and manufacturing techniques, these organizations empower local scientists and technicians. This knowledge transfer enhances the region's scientific workforce, enabling them to contribute meaningfully to global scientific endeavors. Such skill development not only democratizes access to science but also empowers local communities to actively participate in shaping the future of research.
  • Accelerating Drug Discovery and Development: South America's diverse biological resources offer a rich pool for drug discovery. CDMOs in the region can play a critical role in expediting the development of pharmaceuticals that address diseases prevalent not only in South America but also globally. This acceleration in drug discovery contributes to democratizing access to effective medical treatments, particularly for neglected tropical diseases and conditions that disproportionately affect underserved populations.
  • Affordable and Accessible Innovation: CDMOs in South America can leverage the region's cost advantages to produce scientific tools, diagnostics, and pharmaceuticals at a more affordable rate. This affordability translates into accessible pricing, making scientific advancements and medical innovations more attainable for resource-limited regions. By reducing financial barriers, CDMOs contribute to democratizing access to critical scientific tools and healthcare solutions.
  • Promoting Regulatory Harmonization: The establishment of CDMOs in South America encourages regulatory harmonization and alignment with international standards. This streamlines the development and manufacturing processes, facilitating the global distribution of scientific advancements. A harmonized regulatory environment ensures that scientific innovations originating from the region are readily accepted and integrated into the broader scientific community, promoting a more equitable dissemination of knowledge.
  • Strengthening Global Scientific Networks: CDMOs serve as bridges between South American scientific communities and the global network of researchers, experts, and institutions. This connectivity fosters the exchange of ideas, collaborations, and partnerships on an international scale. By strengthening these networks, CDMOs contribute to democratizing access to a vast pool of scientific expertise, enabling researchers from different regions to collaborate and collectively address complex challenges.


In conclusion, CDMOs in South America play a critical role in democratizing access to science. As we navigate the path to an inclusive scientific future, the role of CDMOs in South America becomes ever more pivotal, ensuring that the benefits of scientific progress are shared by all. More than that, there is now a change in the profile of the CDMOs: rather than competing directly with larger CDMOs, newer and smaller CDMOs, such as Biotimize, are aiming to provide a more cost-effective path for companies and are building stronger relationships early and providing more services to attract first-time founders, small teams, and companies that can't play with traditional CDMOs.


Rigorous company in relation to the general data protection law (LGPD)

Biotimize - Biotechnology as a Service is committed to complying with the laws that protect the privacy of the data of its employees, partners and the general public.
See how we deal with the information collected:

What are the data types? Personal data:
”Information related to the identified or viral person”, for example: first name, last name, date of birth, personal documents, home or business address, telephone, email and IP address.

Sensitive Personal data:
These are the data that refer to racial or ethnic origin, religious conviction, political opinion, union affiliation or organization of a religious, philosophical or political nature. Sensitive personal data as well are those related to health or sex life, genetic or biometric data.

What data does our Company collect? Our company handles data from employees, partners and service providers, being duly compliant with the LGPD.
On the website, the company collects data through the voluntary and consensual completion of forms, e-books and contact to receive the newsletter.

Is there automatic data collection? Biotimize - Biotechnology as a Service does not automatically collect data in each access to the website.

How do they use my data? The personal data provided by users who fill in the forms are used solely to provide feedback at the user's request (individual or legal entity interested in our company's products and services).
Once the service is completed, such data is deleted.

Have you got any questions? Talk to the Data Protection Manager (DPO) by email:
You will be able to clarify doubts related to the processing of personal data.